Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ENvue Medical (FEED) Income from Continuing Operations (2017 - 2025)

Historic Income from Continuing Operations for ENvue Medical (FEED) over the last 11 years, with Q3 2025 value amounting to $510000.0.

  • ENvue Medical's Income from Continuing Operations rose 15110.22% to $510000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $74000.0, marking a year-over-year decrease of 9831.05%. This contributed to the annual value of $3.8 million for FY2024, which is 0.0% changed from last year.
  • ENvue Medical's Income from Continuing Operations amounted to $510000.0 in Q3 2025, which was up 15110.22% from -$4.0 million recorded in Q2 2025.
  • Over the past 5 years, ENvue Medical's Income from Continuing Operations peaked at $5.6 billion during Q4 2022, and registered a low of -$6.7 million during Q3 2021.
  • In the last 5 years, ENvue Medical's Income from Continuing Operations had a median value of -$955000.0 in 2022 and averaged $293.3 million.
  • In the last 5 years, ENvue Medical's Income from Continuing Operations plummeted by 62396.96% in 2021 and then skyrocketed by 2119669.46% in 2022.
  • Quarter analysis of 5 years shows ENvue Medical's Income from Continuing Operations stood at $26.1 million in 2021, then soared by 21196.69% to $5.6 billion in 2022, then plummeted by 99.88% to $6.7 million in 2023, then decreased by 9.38% to $6.0 million in 2024, then crashed by 91.54% to $510000.0 in 2025.
  • Its Income from Continuing Operations stands at $510000.0 for Q3 2025, versus -$4.0 million for Q2 2025 and -$2.5 million for Q1 2025.